- Home
- BZFD vs ZURA Comparison
BZFD vs ZURA Comparison
Compare BZFD & ZURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BZFD
- ZURA
- Stock Information
- Founded
- BZFD 2006
- ZURA 2022
- Country
- BZFD United States
- ZURA United States
- Employees
- BZFD N/A
- ZURA N/A
- Industry
- BZFD Movies/Entertainment
- ZURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BZFD Consumer Discretionary
- ZURA Health Care
- Exchange
- BZFD Nasdaq
- ZURA Nasdaq
- Market Cap
- BZFD 72.8M
- ZURA 76.6M
- IPO Year
- BZFD N/A
- ZURA N/A
- Fundamental
- Price
- BZFD $1.86
- ZURA $1.21
- Analyst Decision
- BZFD
- ZURA Buy
- Analyst Count
- BZFD 0
- ZURA 7
- Target Price
- BZFD N/A
- ZURA $14.33
- AVG Volume (30 Days)
- BZFD 259.6K
- ZURA 326.3K
- Earning Date
- BZFD 05-07-2025
- ZURA 05-08-2025
- Dividend Yield
- BZFD N/A
- ZURA N/A
- EPS Growth
- BZFD N/A
- ZURA N/A
- EPS
- BZFD 0.34
- ZURA N/A
- Revenue
- BZFD $188,899,000.00
- ZURA N/A
- Revenue This Year
- BZFD $89.62
- ZURA N/A
- Revenue Next Year
- BZFD $4.50
- ZURA N/A
- P/E Ratio
- BZFD $5.51
- ZURA N/A
- Revenue Growth
- BZFD N/A
- ZURA N/A
- 52 Week Low
- BZFD $1.61
- ZURA $0.97
- 52 Week High
- BZFD $5.68
- ZURA $6.35
- Technical
- Relative Strength Index (RSI)
- BZFD 47.05
- ZURA 43.46
- Support Level
- BZFD $1.73
- ZURA $1.17
- Resistance Level
- BZFD $2.11
- ZURA $1.55
- Average True Range (ATR)
- BZFD 0.15
- ZURA 0.14
- MACD
- BZFD 0.02
- ZURA -0.02
- Stochastic Oscillator
- BZFD 48.42
- ZURA 7.83
About BZFD BuzzFeed Inc.
BuzzFeed Inc is a tech-powered, diversified media company that reaches hundreds of millions globally through its cross-platform news and entertainment network. The company produces articles, lists, quizzes, videos, and original series; lifestyle content through brands including Tasty, social food network; original reporting and investigative journalism through BuzzFeed News and HuffPost; an industry- affiliate business, strategic partnerships, licensing and product development through BuzzFeed Commerce; and original productions across broadcast, cable, SVOD, film and digital platforms for BuzzFeed Studios.
About ZURA Zura Bio Limited
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.